ArriVent BioPharma Inc — Dividend History & Yield (NASDAQ:AVBP) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Dividends per share — — Dividend yield % — — Payout ratio % — —

Notícias

Cantor Fitzgerald reitera classificação acima da média para ações da ArriVent

ArriVent stock rating reiterated as Overweight by Cantor Fitzgerald

Oppenheimer reitera classificação acima da média para ações da ArriVent BioPharma

Oppenheimer reiterates Outperform rating on ArriVent BioPharma stock

ArriVent BioPharma (AVBP): Its Leading Asset, Furmonertinib, Supports A Cautious Buy

ArriVent BioPharma: A De-Risked Binary With Near-Term Catalysts (NASDAQ:AVBP)

Cantor Fitzgerald initiates ArriVent BioPharma stock with Overweight rating

ArriVent doses first patient in pivotal phase 3 trial for lung cancer drug

Ações da ArriVent BioPharma iniciam com recomendação de compra pela BTIG devido ao potencial oncológico

ArriVent BioPharma stock initiated with Buy rating at BTIG on oncology potential

Ações da ArriVent BioPharma iniciam com recomendação de compra pela Truist

ArriVent BioPharma stock initiated with Buy rating at Truist on lung cancer drug